Sedana Medical AB (publ) (STO:SEDANA)
Sweden
· Delayed Price · Currency is SEK 13.46
-0.16 (-1.17%)
May 13, 2025, 5:29 PM CET
Sedana Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 187.43 | 178.75 | 153.87 | 122.87 | 159.15 | 141.77 | Upgrade
|
| Revenue Growth (YoY) | 13.66% | 16.17% | 25.23% | -22.80% | 12.26% | 97.88% | Upgrade
|
| Cost of Revenue | 55.4 | 52.61 | 44.89 | 36.79 | 52.45 | 52.87 | Upgrade
|
| Gross Profit | 132.03 | 126.14 | 108.98 | 86.07 | 106.71 | 88.9 | Upgrade
|
| Selling, General & Admin | 158.78 | 156.6 | 154.74 | 169.94 | 148.31 | 102.42 | Upgrade
|
| Research & Development | 20.1 | 20.29 | 20.81 | 19.94 | 19.7 | 7.86 | Upgrade
|
| Other Operating Expenses | 0.03 | 0.03 | -0.02 | 0.12 | -0.11 | -0.02 | Upgrade
|
| Operating Expenses | 178.91 | 176.92 | 175.53 | 190.01 | 167.9 | 110.26 | Upgrade
|
| Operating Income | -46.88 | -50.78 | -66.55 | -103.93 | -61.2 | -21.36 | Upgrade
|
| Interest Expense | -31.29 | -0.18 | -0.22 | -0.26 | -0.24 | -0.19 | Upgrade
|
| Interest & Investment Income | - | 16.49 | 15.17 | 3.58 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 23.96 | 24.52 | -7.42 | 27.68 | 4.07 | -2.56 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | -0 | Upgrade
|
| Pretax Income | -54.22 | -9.95 | -59.02 | -72.93 | -57.37 | -24.1 | Upgrade
|
| Income Tax Expense | 0.55 | 0.73 | 0.59 | 0.57 | 0.6 | 3.04 | Upgrade
|
| Net Income | -54.77 | -10.67 | -59.61 | -73.51 | -57.97 | -27.14 | Upgrade
|
| Net Income to Common | -54.77 | -10.67 | -59.61 | -73.51 | -57.97 | -27.14 | Upgrade
|
| Shares Outstanding (Basic) | 99 | 99 | 99 | 99 | 93 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 99 | 99 | 99 | 93 | 92 | Upgrade
|
| Shares Change (YoY) | - | - | - | 6.85% | 1.54% | 9.27% | Upgrade
|
| EPS (Basic) | -0.55 | -0.11 | -0.60 | -0.74 | -0.62 | -0.30 | Upgrade
|
| EPS (Diluted) | -0.56 | -0.11 | -0.60 | -0.74 | -0.62 | -0.30 | Upgrade
|
| Free Cash Flow | -16.47 | -13.99 | -38.58 | -116.17 | -46.41 | -20.29 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | -0.14 | -0.39 | -1.17 | -0.50 | -0.22 | Upgrade
|
| Gross Margin | 70.44% | 70.57% | 70.83% | 70.06% | 67.05% | 62.71% | Upgrade
|
| Operating Margin | -25.01% | -28.41% | -43.25% | -84.59% | -38.45% | -15.07% | Upgrade
|
| Profit Margin | -29.22% | -5.97% | -38.74% | -59.83% | -36.42% | -19.14% | Upgrade
|
| Free Cash Flow Margin | -8.79% | -7.82% | -25.07% | -94.55% | -29.16% | -14.31% | Upgrade
|
| EBITDA | -45.14 | -48.77 | -64.19 | -100.56 | -56.8 | -16.92 | Upgrade
|
| EBITDA Margin | -24.08% | -27.28% | -41.72% | -81.84% | -35.69% | -11.93% | Upgrade
|
| D&A For EBITDA | 1.74 | 2.01 | 2.36 | 3.38 | 4.4 | 4.44 | Upgrade
|
| EBIT | -46.88 | -50.78 | -66.55 | -103.93 | -61.2 | -21.36 | Upgrade
|
| EBIT Margin | -25.01% | -28.41% | -43.25% | -84.59% | -38.45% | -15.07% | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.